not intubated | emergently intubated | p-value | |
---|---|---|---|
n | 140 | 20 | |
Age, mean ± SD | 76.2 ± 11.08 | 73.3 ± 13.07 | 0.290 |
Male sex, n (%) | 57 (40.7) | 7(35.0) | 0.626 |
Comorbidities and medication, n (%) | |||
Hypertension | 117 (83.6) | 13 (65.0) | 0.047 |
Diabetes mellitus | 33 (23.6) | 4 (20.0) | 0.723 |
Hypercholesterolemia | 42 (30.0) | 4 (20.0) | 0.355 |
Currently smoking | 21 (15.0) | 3 (15.0) | 1.000 |
Previous stroke | 28 (20.0) | 4 (20.0) | 1.000 |
Coronary artery disease | 33 (23.6) | 8 (40.0) | 0.115 |
Peripheral artery disease | 11 (7.9) | 3 (15.0) | 0.290 |
Atrial fibrillation | 47 (33.6) | 7 (35.0) | 0.899 |
Need for dialysis | 1 (0.7) | 0 (0.0) | 0.705 |
Antiplatelet therapy | 52 (37.1) | 6 (30.0) | 0.534 |
Oral anticoagulants | 22 (15.7) | 5 (25.0) | 0.300 |
Statin therapy | 37 (26.4) | 7 (35.0) | 0.422 |
NIHSS on admission, mean ± SD | 13.5 ± 7.06 | 16.6 ± 6.29 | 0.068 |
Premorbid mRS, n (%) | |||
0–2 | 99 (70.7) | 14 (70.0) | 0.95 |
> 2 | 41 (29.3) | 6 (30.0) | |
ASPECTS, mean ± SD a | 8.2 ± 1.64 | 7.7 ± 2.06 | 0.149 |
Use of iv thrombolysis, n (%) | 82 (58.6) | 15 (75.0) | 0.160 |
Site of occlusion, n (%) | |||
Left sided occlusion | 67 (48.2) | 12 (60.0) | 0.324 |
M1 | 61 (43.6) | 10 (54.5) | 0.591 |
M2 | 36 (25.7) | 3 (13.6) | |
ICA | 5 (3.6) | 0 (0.0) | |
ICA + M1/2 | 37 (26.4) | 7 (31.8) | |
P1 | 1 (0.6) | 0 |